News | January 29, 2024
Jubilant Pharmova Singapore to sell its entire 25.8% stake in Sofie Biosciences, USA
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Marks remarkable acceleration in innovation using AI technology
Furthering cell therapy ambition across oncology and autoimmune diseases
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
The new ECO grade is made using renewable feedstock
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Subscribe To Our Newsletter & Stay Updated
